1	Cyclosporin	Cyclosporin	_	_	_	_	_	_	_
2	A	A	_	_	_	_	_	_	_
3	inhibits	inhibit	_	_	_	_	_	_	_
4	monocyte	monocyte	_	_	_	_	_	_	_
5	tissue	tissue	_	_	_	_	_	_	_
6	factor	factor	_	_	_	_	_	_	_
7	activation	activation	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	cardiac	cardiac	_	_	_	_	_	_	_
10	transplant	transplant	_	_	_	_	_	_	_
11	recipients	recipient	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	BACKGROUND	background	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Fibrin	Fibrin	_	_	_	_	_	_	_
4	deposition	deposition	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	thrombosis	thrombosis	_	_	_	_	_	_	_
7	have	have	_	_	_	_	_	_	_
8	been	be	_	_	_	_	_	_	_
9	implicated	implicate	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	both	both	_	_	_	_	_	_	_
12	allograft	allograft	_	_	_	_	_	_	_
13	rejection	rejection	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	vasculopathy	vasculopathy	_	_	_	_	_	_	_
16	after	after	_	_	_	_	_	_	_
17	cardiac	cardiac	_	_	_	_	_	_	_
18	transplantation	transplantation	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Because	because	_	_	_	_	_	_	_
2	monocytes	monocyte	_	_	_	_	_	_	_
3	play	play	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	pivotal	pivotal	_	_	_	_	_	_	_
6	role	role	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	pathophysiology	pathophysiology	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	intravascular	intravascular	_	_	_	_	_	_	_
12	coagulation	coagulation	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	through	through	_	_	_	_	_	_	_
15	their	their	_	_	_	_	_	_	_
16	ability	ability	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	synthesize	synthesize	_	_	_	_	_	_	_
19	tissue	tissue	_	_	_	_	_	_	_
20	factor	factor	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	TF	TF	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	we	we	_	_	_	_	_	_	_
26	asked	ask	_	_	_	_	_	_	_
27	(	(	_	_	_	_	_	_	_
28	1	1	_	_	_	_	_	_	_
29	)	)	_	_	_	_	_	_	_
30	whether	whether	_	_	_	_	_	_	_
31	monocyte	monocyte	_	_	_	_	_	_	_
32	TF	TF	_	_	_	_	_	_	_
33	activation	activation	_	_	_	_	_	_	_
34	occurs	occur	_	_	_	_	_	_	_
35	in	in	_	_	_	_	_	_	_
36	cardiac	cardiac	_	_	_	_	_	_	_
37	transplant	transplant	_	_	_	_	_	_	_
38	recipients	recipient	_	_	_	_	_	_	_
39	and	and	_	_	_	_	_	_	_
40	(	(	_	_	_	_	_	_	_
41	2	2	_	_	_	_	_	_	_
42	)	)	_	_	_	_	_	_	_
43	whether	whether	_	_	_	_	_	_	_
44	monocyte	monocyte	_	_	_	_	_	_	_
45	TF	TF	_	_	_	_	_	_	_
46	expression	expression	_	_	_	_	_	_	_
47	is	be	_	_	_	_	_	_	_
48	affected	affect	_	_	_	_	_	_	_
49	by	by	_	_	_	_	_	_	_
50	treatment	treatment	_	_	_	_	_	_	_
51	with	with	_	_	_	_	_	_	_
52	cyclosporin	cyclosporin	_	_	_	_	_	_	_
53	A	A	_	_	_	_	_	_	_
54	(	(	_	_	_	_	_	_	_
55	CsA	CsA	_	_	_	_	_	_	_
56	)	)	_	_	_	_	_	_	_
57	.	.	_	_	_	_	_	_	_

1	METHODS	methods	_	_	_	_	_	_	_
2	AND	and	_	_	_	_	_	_	_
3	RESULTS	results	_	_	_	_	_	_	_
4	:	:	_	_	_	_	_	_	_
5	We	we	_	_	_	_	_	_	_
6	measured	measure	_	_	_	_	_	_	_
7	levels	level	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	TF	TF	_	_	_	_	_	_	_
10	activity	activity	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	peripheral	peripheral	_	_	_	_	_	_	_
13	blood	blood	_	_	_	_	_	_	_
14	mononuclear	mononuclear	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	highly	highly	_	_	_	_	_	_	_
18	purified	purify	_	_	_	_	_	_	_
19	monocytes/macrophages	monocytes/macrophage	_	_	_	_	_	_	_
20	from	from	_	_	_	_	_	_	_
21	10	10	_	_	_	_	_	_	_
22	consecutive	consecutive	_	_	_	_	_	_	_
23	cardiac	cardiac	_	_	_	_	_	_	_
24	transplant	transplant	_	_	_	_	_	_	_
25	recipients	recipient	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	10	10	_	_	_	_	_	_	_
28	healthy	healthy	_	_	_	_	_	_	_
29	control	control	_	_	_	_	_	_	_
30	subjects	subject	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	TF	TF	_	_	_	_	_	_	_
2	activity	activity	_	_	_	_	_	_	_
3	generated	generate	_	_	_	_	_	_	_
4	by	by	_	_	_	_	_	_	_
5	both	both	_	_	_	_	_	_	_
6	unstimulated	unstimulated	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	endotoxin-stimulated	endotoxin-stimulated	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	was	be	_	_	_	_	_	_	_
11	significantly	significantly	_	_	_	_	_	_	_
12	higher	high	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	transplant	transplant	_	_	_	_	_	_	_
15	recipients	recipient	_	_	_	_	_	_	_
16	than	than	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	control	control	_	_	_	_	_	_	_
19	subjects	subject	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	P<.05	p<.05	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Increased	increase	_	_	_	_	_	_	_
2	monocyte	monocyte	_	_	_	_	_	_	_
3	TF	tf	_	_	_	_	_	_	_
4	expression	expression	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	transplant	transplant	_	_	_	_	_	_	_
7	recipients	recipient	_	_	_	_	_	_	_
8	was	be	_	_	_	_	_	_	_
9	shown	show	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	be	be	_	_	_	_	_	_	_
12	adversely	adversely	_	_	_	_	_	_	_
13	affected	affect	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	treatment	treatment	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	CsA	CsA	_	_	_	_	_	_	_
18	:	:	_	_	_	_	_	_	_
19	TF	TF	_	_	_	_	_	_	_
20	induction	induction	_	_	_	_	_	_	_
21	was	be	_	_	_	_	_	_	_
22	markedly	markedly	_	_	_	_	_	_	_
23	reduced	reduce	_	_	_	_	_	_	_
24	by	by	_	_	_	_	_	_	_
25	CsA	CsA	_	_	_	_	_	_	_
26	serum	serum	_	_	_	_	_	_	_
27	concentrations	concentration	_	_	_	_	_	_	_
28	reaching	reach	_	_	_	_	_	_	_
29	peak	peak	_	_	_	_	_	_	_
30	CsA	CsA	_	_	_	_	_	_	_
31	drug	drug	_	_	_	_	_	_	_
32	levels	level	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Inhibition	Inhibition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	TF	TF	_	_	_	_	_	_	_
4	induction	induction	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	presence	presence	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	high	high	_	_	_	_	_	_	_
10	CsA	CsA	_	_	_	_	_	_	_
11	blood	blood	_	_	_	_	_	_	_
12	concentrations	concentration	_	_	_	_	_	_	_
13	was	be	_	_	_	_	_	_	_
14	also	also	_	_	_	_	_	_	_
15	observed	observe	_	_	_	_	_	_	_
16	when	when	_	_	_	_	_	_	_
17	stimulation	stimulation	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	was	be	_	_	_	_	_	_	_
21	performed	perform	_	_	_	_	_	_	_
22	with	with	_	_	_	_	_	_	_
23	interferon-gamma	interferon-gamma	_	_	_	_	_	_	_
24	or	or	_	_	_	_	_	_	_
25	interleukin-1beta	interleukin-1beta	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	As	as	_	_	_	_	_	_	_
2	shown	show	_	_	_	_	_	_	_
3	by	by	_	_	_	_	_	_	_
4	reverse	reverse	_	_	_	_	_	_	_
5	transcription-polymerase	transcription-polymerase	_	_	_	_	_	_	_
6	chain	chain	_	_	_	_	_	_	_
7	reaction	reaction	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	electrophoretic	electrophoretic	_	_	_	_	_	_	_
10	mobility	mobility	_	_	_	_	_	_	_
11	shift	shift	_	_	_	_	_	_	_
12	assay	assay	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	respectively	respectively	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	treatment	treatment	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	CsA	CsA	_	_	_	_	_	_	_
19	leads	lead	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	decreased	decrease	_	_	_	_	_	_	_
22	TF	TF	_	_	_	_	_	_	_
23	mRNA	mrna	_	_	_	_	_	_	_
24	expression	expression	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	reduced	reduce	_	_	_	_	_	_	_
27	activation	activation	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
31	transcription	transcription	_	_	_	_	_	_	_
32	factor	factor	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	which	which	_	_	_	_	_	_	_
35	is	be	_	_	_	_	_	_	_
36	known	know	_	_	_	_	_	_	_
37	to	to	_	_	_	_	_	_	_
38	contribute	contribute	_	_	_	_	_	_	_
39	to	to	_	_	_	_	_	_	_
40	the	the	_	_	_	_	_	_	_
41	induction	induction	_	_	_	_	_	_	_
42	of	of	_	_	_	_	_	_	_
43	the	the	_	_	_	_	_	_	_
44	TF	TF	_	_	_	_	_	_	_
45	promotor	promotor	_	_	_	_	_	_	_
46	in	in	_	_	_	_	_	_	_
47	human	human	_	_	_	_	_	_	_
48	monocytes	monocyte	_	_	_	_	_	_	_
49	.	.	_	_	_	_	_	_	_

1	CONCLUSIONS	conclusions	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	This	this	_	_	_	_	_	_	_
4	study	study	_	_	_	_	_	_	_
5	demonstrates	demonstrate	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	TF	TF	_	_	_	_	_	_	_
8	activation	activation	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	occurring	occur	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	mononuclear	mononuclear	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	cardiac	cardiac	_	_	_	_	_	_	_
16	transplant	transplant	_	_	_	_	_	_	_
17	recipients	recipient	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	is	be	_	_	_	_	_	_	_
20	inhibited	inhibit	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	treatment	treatment	_	_	_	_	_	_	_
23	with	with	_	_	_	_	_	_	_
24	CsA	CsA	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Inhibition	Inhibition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	monocyte	monocyte	_	_	_	_	_	_	_
4	TF	tf	_	_	_	_	_	_	_
5	induction	induction	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	CsA	CsA	_	_	_	_	_	_	_
8	may	may	_	_	_	_	_	_	_
9	contribute	contribute	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	its	its	_	_	_	_	_	_	_
12	successful	successful	_	_	_	_	_	_	_
13	use	use	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	cardiac	cardiac	_	_	_	_	_	_	_
16	transplant	transplant	_	_	_	_	_	_	_
17	medicine	medicine	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	might	might	_	_	_	_	_	_	_
20	be	be	_	_	_	_	_	_	_
21	useful	useful	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	managing	manage	_	_	_	_	_	_	_
24	further	further	_	_	_	_	_	_	_
25	settings	setting	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	vascular	vascular	_	_	_	_	_	_	_
28	pathology	pathology	_	_	_	_	_	_	_
29	also	also	_	_	_	_	_	_	_
30	known	know	_	_	_	_	_	_	_
31	to	to	_	_	_	_	_	_	_
32	involve	involve	_	_	_	_	_	_	_
33	TF	TF	_	_	_	_	_	_	_
34	expression	expression	_	_	_	_	_	_	_
35	and	and	_	_	_	_	_	_	_
36	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
37	activation	activation	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

